Colorado was the venue of the 12th International Hyperbaric Symposium of the International Hyperbaric Medicine Association. With more than 12 countries present, the event focused on advances in hyperbaric medicine in the 21st century. The three-day conference was filled with a brilliant and diverse group of cutting-edge hyperbaric professionals, academic researchers, all eager to share their latest work and findings
Stroke is the third leading cause of death in the United States and a major source of disability. It is not only devastating to the patient and the family, but also creates a large financial drain on resources. In stroke it is often stated that most recovery takes place in the first three months. However, sequential SPECT scanning has indicated
What is the relationship between the pressure of treatment and the medical results? Can a dose / response curve be established depending on the treatment pressure and the exposure time? To answer these questions, Dr. Gustavo Javier Breitbart introduces the concept of efficiency and its differences regarding effectiveness. In summary, the effectiveness of a treatment is to achieve the objectives
With the opening of a Hyperbaric Medicine Unit at Hospital Quirónsalud Infanta Luisa in Seville, BioBarica joined the Hospital Group Quirónsalud, the largest network in Spain and Europe. Quirónsalud has more than 60 years of history in health care and covers all medical specialties in its more than 70 care centers distributed in Spain. This alliance projects a great future
The largest network of Hyperbaric Oxygenation treatments arrived to Italy with Performa di Crocicchia, new distributor located in the city of Rome. It is a company with many years of experience, specialized in the distribution of products and medical devices for rehabilitation and health care. To learn more about Performa di Crocicchia, you can visit http://www.performasrl.it Contact Performa di
From 2 to 3 June, BioBarica will be attending the V International Aepromo Congress, declared “of sanitary interest” by the Health Ministry of the Community of Madrid. The V International Aepromo Congress will take place in the Faculty of Medicine of the Complutense University of Madrid and BioBarica will have a space to demonstrate its Hyperbaric Chambers to the attendees.
At BioBarica, we focus on the promotion of Hyperbaric Medicine and we work to ensure that more and more centers offer Hyperbaric Oxygen Therapy (HBOT) to as many patients as possible. Hyperbaric Oxygen Therapy (HBOT) is safe and non-invasive, it significantly increases the amount of oxygen available in blood plasma – this is called hyperoxia – and triggers multiple positive
The Argentine Investment and International Trade Agency presented the 2016 Export Award and BioBarica obtained a special mention in the category “Opening new markets”. The event, which took place in the Hall of the Indigenous Peoples of the Government House, awarded to 11 other companies and national institutions for their achievements in the field of export during this year. BioBarica